From interferant anion to neuromodulator: Ascorbate oxidizes its way to respectability

Electrochemical Methods for Neuroscience

Volumn , Issue , 2006, Pages 149-165

  Rebec, George V ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85057674780     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (87)

1. Adams, R. N., Probing brain chemistry with electroanalytical techniques, Anal. Chem., 48, 1128A, 1976.
2. Adams, R. N., In vivo electrochemical measurements in the CNS, Prog. Neurobiol., 35, 297, 1990.
3. Carpenter, K. J., The History of Scurvy and Vitamin C, Cambridge, New York, 1986.
4. Spector, R., Micronutrient homeostasis in mammalian brain and cerebrospinal fluid, J. Neurochem., 53, 1667, 1989.
5. Tolbert, L. C., Thomas, T. N., Middaugh, L. D., and Zemp, J. W., Effect of ascorbic acid on neurochemical behavioral and physiological systems mediated by catecholamines, Life Sci., 25, 2189, 1979.
6. Rice, M. E. and Nicholson, C., Interstitial ascorbate in turtle brain is modulated by release and extracellular volume change, J. Neurochem., 49, 1096, 1987.
7. Tsukaguchi, H., Tokui, T., Mackenzie, B., Berger, U. V., Chen, X. Z., Wang, Y., Brubaker, R. F., and Hediger, M. A., A family of mammalian NaC-dependent L-ascorbic acid transporters, Nature, 399, 70, 1999.
8. Berger, U. V. and Hediger, M. A., The vitamin C transporter SVCT2 is expressed by astrocytes in culture but not in situ, Neuroreport, 11, 1395, 2000.
9. Rice, M. E. and Russo-Menna, I., Differential compartmentalization of brain ascorbate and glutathione between neurons and glia, Neuroscience, 82, 1213, 1998.
10. Oke, A. F., May, L., and Adams, R. N., Ascorbic acid distribution patterns in human brain, In Beyond Deficiency: New Views on the Function and Health Effects on Vitamins (Annals of the New York Academy of Sciences), New York Academy of Sciences, New York, p. 1, 1992.
11. Schenk, J. O., Miller, E., Gaddis, R., and Adams, R. N., Homeostatic control of ascorbate concentration in CNS extracellular fluid, Brain Res., 253, 353, 1982.
12. Basse-Tomusk, A. and Rebec, G. V., Regional distribution of ascorbate and 3,4-dihydroxyphenylacetic acid (DOPAC) in rat neostriatum, Brain Res., 538, 29, 1991.
13. Englard, S. and Seifter, S., The biochemical functions of ascorbic acid, Ann. Rev. Nutr., 6, 365, 1986.
14. Diliberto, E. J. and Allen, P. L., Mechanism of dopamine-beta-hydroxylation. Semidehydroascorbate as the enzyme oxidation product of ascorbate, J. Biol. Chem., 256, 3385, 1981.
15. Halliwell, B., Oxygen radicals as key mediators in neurological disease: fact or fiction, Ann. Neurol., 32, S10, 1992.
16. Niki, E., Action of ascorbic acid as a scavenger of active and stable oxygen radicals, Am. J. Clin. Nutr., 54, S1119, 1991.
17. Rice, M. E., Ascorbate regulation and its neuroprotective role in the brain, Trends Neurosci., 23, 209, 2000.
18. Halliwell, B. and Gutteridge, J. M. C., Free Radicals in Biology and Medicine, 3rd ed., Oxford University Press, New York, 1999.
19. Connor, J. R., Evidence for iron mismanagement in the brain in neurological disorders, In Metals and Oxidative Damage in Neurological Disorders, Connor, J. R., Ed., Plenum Press, New York, p. 23, 1997.
20. Rebec, G. V. and Pierce, R. C., A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission, Prog. Neurobiol., 43, 537, 1994.
21. Fillenz, M., O’Neill, R. D., and Grunewald, R. A., Changes in extracellular brain ascorbate concentration as an index of excitatory aminoacid release, In Monitoring Neurotransmitter Release During Behaviour, Joseph, M. H., Fillenz, M., MacDonald, A., and Marsden, C. A., Eds., Ellis Norwood, Chichester, p. 144, 1986.
22. Kissinger, P. T., Hart, J. B., and Adams, R. N., Voltammetry in brain tissue: a new neurophysiological measurement, Brain Res., 55, 209, 1973.
23. Conti, J. C., Strope, E., Adams, R. N., and Marsden, C. A., Voltammetry in brain tissue: chronic recording of stimulated dopamine and 5-hydroxytryptamine release, Life Sci., 23, 2705, 1978.
24. Justice, J. B. Jr., Introduction to in vivo voltammetry, In Voltammetry in the Neurosciences, Principles, Methods, and Applications, Justice, J. B. Jr., Ed., Humana Press, Clifton, New Jersey, USA, p. 3, 1987.
25. Gonon, F. G., Frombarlet, C. M., Buda, M. J., and Pujol, J. F., Electrochemical treatment of pyrolytic carbon fiber electrodes, Anal. Chem., 53, 1386, 1981a.
26. Gonon, F., Buda, M., Cespuglio, R., Jouvet, M., and Pujol, J. F., Voltammetry in the striatum of chronic freely moving rats: detection of catechols and ascorbic acid, Brain Res., 223, 69, 1981b.
27. Falat, L. and Cheng, H. Y., Voltammetric differentiation of ascorbic acid and dopamine at an electrochemically treated graphite/epoxy electrode, Anal. Chem., 54 (12), 2108, 1982.
28. Rice, M. E., Galus, Z., and Adams, R. N., Graphite paste electrodes. Effects of paste composition and surface states on electron-transfer rates, J. Electroanal. Chem., 143, 89, 1983.
29. Stamford, J. A., Kruk, Z. L., and Miller, J., Regional differences in extracellular ascorbic levels in the rat brain determined by high speed cyclic voltammetry, Brain Res., 299, 289, 1984.
30. O’Neill, R. D., Grunewald, R. A., Fillenz, M., and Albery, W. J., Linear sweep voltammetry with carbon paste electrodes in the rat striatum, Neuroscience, 7, 1945, 1982.
31. Mueller, K., Repeated administration of high doses of amphetamine increases release of ascorbic acid in caudate but not nucleus accumbens, Brain Res., 494, 30, 1989.
32. Pierce, R. C. and Rebec, G. V., Stimulation of both D1 and D2 receptors increases behavioral activation and ascorbate release in the neostriatum of freely moving rats, Eur. J. Pharmacol., 191, 295, 1990.
33. Kaufmann, P., Wiens, W., Dirks, M., and Krehbiel, D., Changes in social behavior and brain catecholamines during the development of ascorbate deficiency in guinea pigs, Behav. Process., 13, 13, 1986.
34. Rebec, G. V. and Wang, Z., Behavioral activation in rats requires endogenous ascorbate release in striatum, J. Neurosci., 21, 668, 2001.
35. Bolam, J. P., Hanley, J. J., Booth, P. A., and Bevan, M. D., Synaptic organisation of the basal ganglia, J. Anat., 196, 527, 2000.
36. Groves, P. M., A theory of the functional organization of the neostriatum and the neostriatal control of voluntary movement, Brain Res. Rev., 5, 109, 1983.
37. Parent, A., Cote, P. Y., and Lavoie, B., Chemical anatomy of primate basal ganglia, Prog. Neurobiol., 46, 131, 1995.
38. Basse-Tomusk, A. and Rebec, G. V., Corticostriatal and thalamic regulation of amphetamine-induced ascorbate release in the neostriatum, Pharmacol. Biochem. Behav., 35, 55, 1990.
39. O’Neill, R. D., Grunewald, R. A., Fillenz, M., and Albery, W. J., The effect of unilateral cortical lesions on the circadian changes in rat striatal ascorbate and homovanillic acid levels measured in vivo using voltammetry, Neurosci. Lett., 42, 105, 1983.
40. Pierce, R. C., Miller, D. M., Reising, D., and Rebec, G. V., Unilateral neostriatal kainate but not 6-0HDA lesions block dopamine agonist-induced ascorbate release in the neostriatum of freelymoving rats, Brain Res., 597, 138, 1992.
41. Cammack, J., Ghasemzadeh, B., and Adams, R. N., The pharmacological profile of glutamate-evoked ascorbic acid efflux measured by in vivo electrochemistry, Brain Res., 565, 17, 1991.
42. Pierce, R. C. and Rebec, G. V., Intraneostriatal administration of glutamate antagonists increases behavioral activation and decreases neostriatal ascorbate via non-dopaminergic mechanisms, J. Neurosci., 13, 4272, 1993.
43. O’Neill, R., The measurement of brain ascorbate in vivo and its link with excitatory amino acid neurotransmission, In Neuromethods Vol. 27: Voltammetric Methods in Brain Systems, Boulton, A., Baker, G., and Adams, R. N., Eds., Humana Press Inc, Clifton, New Jersey, USA, p. 221, 1995.
44. Rebec, G. V., Witowski, S. R., Sandstrom, M. I., Rostand, R. D., and Kennedy, R. T., Extracellular ascorbate modulates cortically evoked glutamate dynamics in rat striatum, Neurosci. Lett., 378, 166, 2005.
45. Balazs, R., Bridges, R. J., and Cotman, C. W., Excitatory Amino Acid Transmission in Health and Disease, Oxford University Press, New York, 2006.
46. Kanai, Y., Trotti, D., Nussberger, S., and Hediger, M. A., The high-affinity glutamate transporter family: structure function and physiological relevance, In Neurotransmitter Transporters-Structure Function and Regulation, Reith, M. E. A., Ed., Humana Press, Totowa, New Jersey, USA, p. 171, 1997, (Contemporary Neuroscience).
47. Torp, R., Danbolt, N. C., Babaie, E., Bjoras, M., Seeberg, E., Storm-Mathisen, J., and Otterson, O. P., Differential expression of two glial glutamate transporters in the rat brain: an in situ hybridization study, Eur. J. Neurosci., 6, 936, 1994.
48. Mueller, K. and Haskett, C., Effects of haloperidol on amphetamine-induced increases in ascorbic acid as determined by voltammetry in vivo, Pharmacol. Biochem. Behav., 27, 231, 1987.
49. Zetterstrom, T., Wheeler, D. B., Boutelle, M. G., and Fillenz, M., Striatal ascorbate and its relationship to dopamine receptor stimulation and motor activity, Eur. J. Neurosci., 3, 940, 1991.
50. Christensen, J. C., Wang, Z., and Rebec, G. V., GABA infusion in substantia nigra pars reticulata inhibits ascorbate release in ipsilateral striatum, Neurosci. Lett., 280, 191, 2000.
51. Kamata, K., Wilson, R. L., Alloway, K. D., and Rebec, G. V., Multiple amphetamine injections reduce the release of ascorbic acid in the neostriatum of the rat, Brain Res., 362, 331, 1986.
52. Pierce, R. C., Clemens, A. J., Grabner, C. P., and Rebec, G. V., Amphetamine promotes neostriatal ascorbate release via a nigro-thalamo-corticoneostriatal loop, J. Neurochem., 63, 1499, 1994.
53. Wilson, R. L. and Wightman, R. M., Systemic and nigral application of amphetamine both cause an increase in extracellular concentration of ascorbate in the caudate nucleus of the rat, Brain Res., 339, 219, 1985.
54. Phebus, L. A., Roush, M. E., and Clemens, J. A., Effect of direct and indirect dopamine agonists on brain extracellular ascorbate levels in the striatum and nucleus accumbens of awake rats, Life Sci., 47, 1317, 1990.
55. Yount, S. E., Kraft, M. E., Pierce, R. C., Langley, P. E., and Rebec, G. V., Acute and long-term amphetamine treatments alter extracellular ascorbate in neostriatum but not nucleus accumbens of freely moving rats, Life Sci., 49, 1237, 1991.
56. Calabresi, P., Demurtas, M., and Bernardi, G., The neostriatum beyond the motor function: experimental and clinical evidence, Neuroscience, 78, 39, 1997.
57. Graybiel, A. M., The basal ganglia and chunking of action repertoires, Neurobiol. Learn. Mem., 70, 119, 1998.
58. Middleton, F. A. and Strick, P. L., Basal ganglia output and cognition: evidence from anatomical behavioral and clinical studies, Brain Cogn., 42, 183, 2000.
59. Bennett, B. D. and Wilson, C. J., Synaptology and physiology of neostriatal neurones, In Brain Dynamics and the Striatal Complex, Miller, R. and Wickens, J., Eds., Harwood Academic Publishers, Australia, 2000.
60. Kiyatkin, E. A. and Rebec, G. V., Dopaminergic modulation of glutamate-induced excitations of neurons in the neostriatum and nucleus accumbens of awake unrestrained rats, J. Neurophysiol., 75, 142, 1996.
61. Gardiner, T. W., Armstrong-James, M., Caan, A. W., Wightman, R. M., and Rebec, G. V., Modulation of neostriatal activity by iontophoresis of ascorbic acid, Brain Res., 344, 181, 1985.
62. Pierce, R. C. and Rebec, G. V., Iontophoresis in the neostriatum of awake unrestrained rats: differential effects of dopamine glutamate and ascorbate on motor- and nonmotor-related neurons, Neuroscience, 67, 313, 1995.
63. Kiyatkin, E. A. and Rebec, G. V., Ascorbate modulates glutamate-induced excitations of striatal neurons, Brain Res., 812, 14, 1998.
64. Majewska, M. D., Bell, J. A., and London, E. D., Regulation of the NMDA receptor by redox phenomena-inhibitory role of ascorbate, Brain Res., 537, 328, 1990.
65. Cortright, J. J. and Rebec, G. V., Ascorbate modulation of sensorimotor processing in striatum of freely moving rats, Brain Res., 1092, 108, 2006.
66. Kiyatkin, E. A. and Rebec, G. V., Modulation of striatal neuronal activity by glutamate and GABA: iontophoresis in awake, unrestrained rats, Brain Res., 822, 88, 1999.
67. Rebec, G. V., Barton, S. J., and Ennis, M. D., Dysregulation of ascorbate in the striatum of behaving mice expressing the Huntington’s disease gene, J. Neurosci., 22, RC202: 1-6, 2002.
68. Rebec, G. V., Barton, S. J., Marseilles, A. M., and Collins, K., Ascorbate treatment attenuates the Huntington behavioral phenotype in mice, Neuroreport, 14 (9), 1263, 2003.
69. Rebec, G. V., Conroy, S. K., and Barton., S. J., Hyperactive striatal neurons in symptomatic Huntington R6/2 mice: variations with behavioral state and repeated ascorbate treatment, Neuroscience, 137, 327, 2006.
70. Huntington’s Disease Collaborative Group, A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes, Cell, 72, 971, 1993.
71. Luthi-Carter, R., Strand, A., Peters, N. L., Solano, S. M., Hollingsworth, Z. R., Menon, A. S., Frey, A. S. et al., Decreased expression of striatal signaling genes in a mouse model of Huntington’s disease, Hum. Mol. Genet., 9, 1259, 2000.
72. Panov, A. V., Gutekunst, C. A., Leavitt, B. R., Hayden, M. R., Burke, J. R., Strittmatter, W. J., and Greenamyre, J. T., Early mitochondrial calcium defects in Huntington’s disease are a direct effect of polyglutamines, Nat. Neurosci., 5, 731, 2002.
73. Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M. et al., Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice, Cell, 87, 493, 1996.
74. Carter, R. J., Lione, L. A., Humby, T., Mangiarini, L., Mahal, A., Bates, G. P., Dunnett, S. B., and Morton, A. J., Characterization of progressive motor deficits in mice transgenic for the human Huntington’s disease mutation, J. Neurosci., 19, 3248, 1999.
75. Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., and Bates, G. P., Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation, Cell, 90, 537, 1997.
76. Klapstein, G. J., Fisher, R. S., Zanjani, H., Cepeda, C., Jokel, E. S., Chesselet, M. F., and Levine, M. S., Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington’s disease transgenic mice, J. Neurophysiol., 86, 2667, 2001.
77. Rebec, G. V., Langley, P. E., Pierce, R. C., Wang, Z., and Heidenreich, B. A., A simple micromanipulator for multiple uses in freely moving rats: electrophysiology, voltammetry, and simultaneous intracerebral infusions, J. Neurosci. Methods, 47, 53, 1993.
78. Rebec, G. V., Christensen, J. R. C., Guerra, C., and Bardo, M. T., Regional and temporal differences in dopamine efflux in the nucleus accumbens during free-choice novelty, Brain Res., 776, 61, 1997.
79. Garris, P. A., Christensen, J. R. C., Rebec, G. V., and Wightman, R. M., Real-time measurement of electrically evoked extracellular dopamine in the striatum of freely moving rats, J. Neurochem., 68, 152, 1997.
80. Rebec, G. V. and Wang, Z., Microtechnology for monitoring real-time electrical and chemical events at the neuronal level in freely behaving animals, Proc. IEEE-EMBS Asia-Pacific Conf. Biomed. Eng., 2, 511, 2000.
81. Yavich, L., A new technique for measuring the temporal characteristics of the carbon fibre microelectrodes in in vivo voltammetry at millisecond time intervals, J. Neurosci. Methods, 84, 29, 1998.
82. Lievens, J.-C., Woodman, B., Mahal, A., Spasic-Boscovic, O., Samuel, D., Kerkerian-Le Goff, L., and Bates, G. P., Impaired glutamate uptake in the R6 Huntington’s disease transgenic mice, Neurobiol. Dis., 8, 807, 2001.
83. Andersen, J. K., Oxidative stress in neurodegeneration: cause or consequence, Nat. Rev. Neurosci. Neurodegeneration, 5, S18, 2004, http://www.nature.com/focus/neurodegen/.
84. Barnham, K. J., Masters, C. L., and Bush, A. I., Neurodegenerative diseases and oxidative stress, Nat. Rev. Drug Discov., 3, 205, 2004.
85. Coyle, J. T. and Puttfarcken, P., Oxidative stress, glutamate, and neurodegenerative disorders, Science, 262, 689, 1993.
86. Trotti, D., Danbolt, N. C., and Volterra, A., Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration, Trends Pharmacol. Sci., 19, 328, 1998.
87. Levine, M. S., Klapstein, G. J., Koppel, A., Gruen, E., Cepeda, C., Vargas, M. E., Jokel, E. S. et al., Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington’s disease, J. Neurosci. Res., 58, 515, 1999.